Pharmacophore-based 3D-QSAR of HIF-1 Inhibitors

Cited 12 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJ Y Chung-
dc.contributor.authorF A Pasha-
dc.contributor.authorS J Cho-
dc.contributor.authorMi Sun Won-
dc.contributor.authorJung Joon Lee-
dc.contributor.authorKyeong Lee-
dc.date.accessioned2017-04-19T09:13:31Z-
dc.date.available2017-04-19T09:13:31Z-
dc.date.issued2009-
dc.identifier.issn0253-6269-
dc.identifier.uri10.1007/s12272-009-1301-3ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/8890-
dc.description.abstract(Aryloxyamino)benzoic acids and nicotinic/isonicotinic acids represent an important new class of small molecules that inhibit the activation of Hypoxia-Inducible Factor (HIF)-1. In order to understand the factors affecting inhibitory potency of HIF-1 inhibitors, 3 dimensional-quantitative structure activity relationship (3D-QSAR) studies were performed. Since no receptor structure are available, the pharmacophore-based alignment was used for comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The CoMFA and CoMSIA models gave reasonable statistics (CoMFA: q2 = 0.564, r2=0.945; CoMSIA: q2 = 0.575, r2=0.929). Both CoMFA and CoMSIA results indicate that the steric interaction is a major factor, while CoMSIA suggests importance of hydrogen bonding. These findings about steric and H-bonding effects can be useful to design new inhibitors.-
dc.publisherPharmaceutical Soc Korea-
dc.titlePharmacophore-based 3D-QSAR of HIF-1 Inhibitors-
dc.title.alternativePharmacophore-based 3D-QSAR of HIF-1 Inhibitors-
dc.typeArticle-
dc.citation.titleArchives of Pharmacal Research-
dc.citation.number3-
dc.citation.endPage323-
dc.citation.startPage317-
dc.citation.volume32-
dc.contributor.affiliatedAuthorMi Sun Won-
dc.contributor.affiliatedAuthorJung Joon Lee-
dc.contributor.affiliatedAuthorKyeong Lee-
dc.contributor.alternativeName정재윤-
dc.contributor.alternativeNamePasha-
dc.contributor.alternativeName조승주-
dc.contributor.alternativeName원미선-
dc.contributor.alternativeName이정준-
dc.contributor.alternativeName이경-
dc.identifier.bibliographicCitationArchives of Pharmacal Research, vol. 32, no. 3, pp. 317-323-
dc.identifier.doi10.1007/s12272-009-1301-3-
dc.subject.keyword3D-QSAR-
dc.subject.keywordCoMFA-
dc.subject.keywordCoMSIA-
dc.subject.keyworddrug design-
dc.subject.keywordHIF-1 inhibitor-
dc.subject.keywordpharmacophore-
dc.subject.local3D-QSAR-
dc.subject.localCoMFA-
dc.subject.localCoMSIA-
dc.subject.localdrug design-
dc.subject.localDrug design-
dc.subject.localHIF-1 inhibitor-
dc.subject.localpharmacophore-
dc.subject.localPharmacophore-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Genomic Medicine Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.